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SUMMARY
Objective: We evaluated whether endotracheal tube (ETT) intracuff alkalinized lidocaine was superior to sa-
line in blunting emergence coughing, postoperative sore throat, and hoarseness in smokers. Methods: In our 
prospective, double-blind trial, we enrolled 50 smoking patients undergoing surgery under general anesthesia 
including nitrous oxide (N2O). Patients were randomly allocated to receive either ETT intracuff 2% lidocaine 
plus 8.4% sodium bicarbonate (L group), or ETT intracuff 0.9% saline (S group). The ETT cuff was inflated 
to achieve a cuff pressure that prevented air leak during positive pressure ventilation. Incidence of emergence 
coughing, sore throat, and hoarseness were analyzed. The volume of inflation solution, the intracuff pressure, 
the duration of anesthesia, the time elapsed to extubation after discontinuation of anesthesia, and the volume 
of the inflation solution and the air withdrawn from the ETT cuff were also recorded. Results: Intracuff alka-
linized 2% lidocaine was superior to saline in blunting emergence coughing (p < 0.001). The incidence of sore 
throat was significantly lower in the L group at the post-anesthesia care unit (PACU) (p = 0.02). However, at 
24 hours after extubation, sore throat incidence was similar in both groups (p = 0.07). Incidence of hoarse-
ness was similar in both groups. Intracuff pressure in the saline group increased with time while the intracuff 
pressure in the lidocaine group remained constant. Conclusion: The present study demonstrated that the 
intracuff alkalinized 2% lidocaine was superior to saline in decreasing the incidence of emergence coughing 
and sore throat during the postoperative period in smokers.
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RESUMO
O efeito do preenchimento do balonete do tubo traqueal com  
lidocaína alcalinizada a 2% em bloquear tosse, dor de garganta  
e rouquidão em fumantes 
Objetivo: Avaliar se o tubo endotraqueal (TET) com balonete preenchido com lidocaína alcalinizada foi 
superior ao preenchimento com solução salina em bloquear tosse, diminuir a dor de garganta e a rouquidão 
no pós-operatório de fumantes. Métodos: Trata-se de ensaio clínico randomizado aleatório, duplo-cego, que 
envolveu 50 pacientes fumantes submetidos à cirurgia sob anestesia geral, incluindo o óxido nitroso (N2O). 
Os pacientes foram alocados aleatoriamente para pertencer ao grupo com balonete do TET com lidocaína a 
2% mais bicarbonato de sódio 8,4% (grupo L), ou com solução salina 0,9% (grupo S). O balonete foi inflado 
para atingir pressão de selo que impedisse a fuga de ar durante a ventilação com pressão positiva. Incidência 
de tosse no despertar, dor de garganta e rouquidão foram analisadas. O volume da solução de insuflação, a 
pressão do balonete, a duração da anestesia, o tempo decorrido para extubação após interrupção da anestesia 
e o volume da solução de insuflação e do ar retirado do balonete também foram registrados. Resultados: 
Lidocaína alcalinizada a 2% foi superior ao preenchimento do balonete com salina em bloquear tosse no 
despertar (p < 0,001). A incidência de dor de garganta foi significativamente menor no grupo L na SRPA 
(p = 0,02); no entanto, nas 24 horas após a extubação, a incidência de dor de garganta foi semelhante nos dois 
grupos (p = 0,07). Incidência de rouquidão foi semelhante nos dois grupos. A pressão do balonete no grupo 
S aumentou com o tempo, enquanto a do grupo L permaneceu constante. Conclusão: O presente estudo 
demonstrou que preenchimento do balonete do TET com lidocaína alcalinizada a 2% foi superior à solução 
salina na redução da incidência de tosse e dor de garganta no despertar da anestesia em fumantes. 
Unitermos: Tabagismo; intubação intratraqueal; lidocaína; tosse; óxido nitroso; rouquidão.
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INTRODUCTION
Smoking remains one of the most common risk factors 
that predispose patients to perioperative complications1-2. 
Although smoking affects a variety of organs, such as heart, 
lung, immune and nervous systems, the respiratory system 
is the most often affected during the perioperative period3. 
General anesthesia and tracheal intubation may contrib-
ute in exacerbating these respiratory complications. The 
emergence period may require special attention, since it 
elicits undesirable and exacerbated airway reflexes. 
Chronic smokers develop laryngeal epithelial inflam-
mation, metaplasia, and dysplasia, which may impair 
laringeal integrity and function3. Erskine et al. evaluated 
airway reflexivity to chemical and mechanical stimula-
tions. They observed an increase in sensitivity in chronic 
smoking patients, which was associated with a higher inci-
dence of laryngospasm, airway obstruction, and decreased 
oxygen saturation4. It has been suggested that because 
smoking induces these chronic changes in the upper air-
way epithelium, there is a greater exposure of subepithelial 
airway receptors to stimuli3. Tracheal intubation results 
in stretch stimuli in the trachea caused by the tube and 
its cuff. Intravenous5-7 and topical7,8 lidocaine has been 
in use for many years in blunting the emergence adverse 
phenomenon after general anesthesia. Targeted delivery of 
lidocaine to the mucosa in contact with the tracheal tube 
(ETT) cuff can be used as a method for decreasing tracheal 
stimuli. When lidocaine is injected into the ETT cuff9,10, it 
spreads through the semi-permeable membrane wall and 
induces anesthetic action in the trachea. This increases 
tolerance to the placement of tracheal11 and tracheotomy12 
tubes. Hemodynamic alterations after tracheal extubation 
are thereby minimized, and the incidence of coughing is 
reduced13,14. However, a study using intracuff non-alkalin-
ized 4% lidocaine in smokers who underwent short proce-
dures (< 90 minutes) failed to demonstrate a decrease in 
emergence cough15.
A reliable technique for improving endotracheal tube 
tolerance while providing smooth and fast extubation has 
not been established in smoking patients. We conducted 
a randomized double-blind clinical trial to study whether 
tracheal tube intracuff 2% alkalinized lidocaine was supe-
rior to saline in blunting emergence coughing, and post-
operative sore throat and hoarseness in smokers who un-
derwent tracheal intubation.
METHODS 
The study was approved by the Research and Ethics Com-
mittee of Faculdade de Medicina de Botucatu. Written in-
formed consent was obtained from each patient. Fifty pa-
tients scheduled for elective gynecological, orthopedic, or 
plastic surgery were enrolled in this prospective, random-
ized double-blind study. All patients were over 18 years of 
age, of either gender, with ASA physical status I or II, and 
their Mallampatti classification was equal to 1. All patients 
were smokers for a period longer than five years, consum-
ing at least five cigarettes a day, and did not interrupt the 
habit before the surgical procedure. Patients undergoing 
laryngeal surgery, with tracheotomy, laryngeal disease, or 
asthma were excluded from the study. Anticipated difficult 
intubation, more than one attempt for intubation, need for 
nasogastric tube, history of respiratory tract infection, and 
contraindication for use of nitrous oxide (N2O) were also 
exclusion criteria. 
This is a posttest-only design research study to evalu-
ate the efficacy of intracuff alkalinized 2% lidocaine in 
reducing the incidence of cough during emergence from 
general anesthesia and tracheal morbidity in smokers. Tra-
cheal morbidity was defined as postoperative hoarseness 
or sore throat. Patients were randomly allocated to receive 
either ETT intracuff alkalinized 2% lidocaine (L group) or 
ETT intracuff 0.9% saline (S group). Before induction, the 
anesthesia provider was given a 20 mL syringe filled with 
0.9% saline or with 2% lidocaine mixed with 8.4% sodium 
bicarbonate, in a 19:1 mL proportion. At the time of intu-
bation, the experimental group (L) received intracuff lido-
caine and the control group (S) received intracuff saline in 
a volume sufficient to establish a cuff pressure that would 
prevent the air from leaking during positive pressure ven-
tilation. The anesthesia provider was blinded to lidocaine 
or saline administration, since all solutions were colorless 
in a volume of 20 mL. A staff nurse, not otherwise involved 
in the study, prepared the solutions. The application of lo-
cal anesthetic by any other means was prohibited. The 
ETT cuffs were lubricated with 4 mL of water-soluble gel 
(KY Gel®, Johnson & Johnson – France) before tracheal in-
tubation in both groups. 
INTRAOPERATIVE PROCEDURES
Patients were premedicated with oral midazolan (7.5 mg) 
one hour before anesthesia induction. Monitoring in-
cluded electrocardiogram, pulse oximetry, capnography, 
and non-invasive blood pressure (NIBP). Both groups re-
ceived a standardized balanced anesthesia management, 
including isoflurane and continuous infusion of sufent-
anil. Neuromuscular blockade was ensured throughout 
surgery, using neuromuscular monitoring, with continu-
ous infusion of rocuronium. The intubation was based on 
the response to ulnar stimulation, performed when the 4th 
stimulus/1st stimulus ratio was equal to zero. A standard 
8.0 mm ID polyvinyl chloride oral cuffed ETT was used in 
males and a 7.5 mm ID was used in females. Continuous 
intracuff pressure was monitored with a pressure monitor 
that included a pressure transducer (Portal Monitor DX 
2020, Dixtal - Manaus, Brazil) connected to a three-way 
stopcock. The ETT pilot balloon and the 20 mL syringe 
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with lidocaine or saline were attached to the other two-
way stopcocks. After inflation of the cuff, the three-way 
stopcock was closed to atmosphere and the initial pres-
sure reading was taken with patient under ventilation 
with 100% oxygen. The volume of the inflation solution 
was noted (T0). N2O was then initiated and the patient was 
ventilated with 60% N2O in oxygen throughout the surgi-
cal procedure. At the end of the surgical procedure, the 
neuromuscular block (NMB) was reversed with neostig-
mine and atropine. The tracheal tube was removed when 
the following signs of complete NMB reversion occurred: 
spontaneous ventilation, response to ulnar stimulation 
such that the 4th stimulus/1st stimulus ratio was greater 
than 0.9, and response to verbal commands (eye opening 
or hand squeezing). 
DATA RECORDED
The volume of inflation solution, the intracuff pressure, 
the duration of anesthesia, the time elapsed to extubation 
after the discontinuation of anesthesia, and the volume of 
the inflation solution and air withdrawn from the ETT 
cuff were recorded. 
The coughing was assessed as present or absent in 
all patients. Coughing was considered absent when no 
coughing or coughing only while removing the ETT cuff 
occurred. It was considered present when the patient 
coughed while breathing regularly or irregularly with the 
ETT in place. An anesthesiologist who did not know to 
which group (L or S) the patient belonged evaluated the 
incidence of emergence coughing (yes/no), sore throat, 
and hoarseness. Sore throat and hoarseness were evalu-
ated at the time of release from the post-anesthesia care 
unit (PACU) and 24 hours after extubation.
LIDOCAINE CONCENTRATION
Four peripheral blood samples were taken during the 
anesthetic-surgical procedure (10, 60, and 120 minutes 
after tracheal intubation, and at the end of anesthesia). 
Samples were placed in tubes containing sodium ethyl-
enediaminetraacetic acid (EDTA) for high performance 
liquid chromatographic (HPLC) analysis of serum lido-
caine concentrations. 
STATISTICAL ANALYSIS
Power analysis suggested that 25 patients in each group 
would allow for detection of a 35% decrease in the inci-
dence of coughing and sore throat for a type I error of 
0.05, a type II error of 0.20, and a power equal to 0.80.
For anthropometrical variables and duration of the 
anesthesia, the Student t test was used. The incidence of 
coughing, sore throat, and hoarseness were compared by 
the chi-square test for multiple variables. Values were con-
sidered significant when p < 0.05.
RESULTS 
All 50 patients enrolled in the study completed it. With 
respect to gender, 74% of the patients were female and 26% 
were male, with no statistical difference within the groups 
(p = 0.33). The groups were similar with respect to patient 
characteristics, as well as in the duration of anesthesia 
(p > 0.05) (Table 1). The mean time elapsed from discon-
tinuation of the anesthesia to extubation was longer for the 
S group when compared with the L group, but no statisti-
cally significant difference was noted (p = 0.052) (Table 1).
INTRACUFF PRESSURE AND VOLUMES
It can be seen in Table 2 that the initial pressure (T0) 
(cm H2O) required to “seal” the trachea and avoid air leak 
during positive pressure ventilation was higher in the L 
group when compared with the S group (17.8 ± 2.1 vs. 
15.9 ± 1.3, respectively; p < 0.05). However, the intracuff 
pressure in the S group increased with time, while in the 
L group it remained constant. Although initially lower, the 
intracuff pressure in the S group is statistically higher than 
the pressure in the L group at the end of the study (T final) 
(20.4 ± 9.1 vs. 16.3 ± 5.7, respectively; p < 0.05) (Table 2). 
In both groups, the intracuff pressure was maintained be-
low the critical tracheal perfusion pressure of 25 cm H2O15.
The initial volume needed to inflate the ETT cuff 
was similar in both groups (S group = 7.21 ± 2.1 and 
L group = 6.9 ± 2.6) (p = 0.77). There was a decrease in 
the volume of the solution withdrawn from the cuff at the 
end of the study, with no statistically significant difference 
between the groups (3% and 10% decrease in S group and 
L group, respectively; p = 0.55). 
Variable
Group
p-value
Saline Lidocaine
Weight (kg) 67.3 ± 12.0 69.3 ± 15.0 0.61
Height (cm) 162.8 ± 7.8 163.7 ± 10.5 0.72
Duration of anesthesia (min) 223.6 ± 99.3 206.6 ± 63.1 0.47
Time elapsed from discontinuation of anesthesia to extubation (min) 14.1 ± 11.6 9.2 ± 4.2 0.05
Table 1 – Anthropometric variables of the patients, duration of anesthesia, and time elapsed from discontinuation of 
anesthesia to extubation. Data shown as mean ± standard deviation
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COUGHING
The incidence of coughing at emergence of general anes-
thesia was considerably lower in the L group (p < 0.001), 
when compared with the S group, demonstrating a benefi-
cial effect of the alkalinized lidocaine in suppressing the 
irritation stimuli of the ETT cuff on the tracheal mucosa 
when compared with the ETT cuff inflation with saline 
(Figure 1).
PLASMA LIDOCAINE ASSESSMENT
The serum concentration of lidocaine in the L group did not 
vary significantly throughout the study. It was readily detect-
able 10 minutes after the inflation of the cuff with the local 
anesthetic, and remained constant throughout the study pe-
riod (T10 = 1.52 ± 0.33; T60 = 1.60 ± 0.71; T120 = 1.60 ± 0.84; 
Tend of anesthesia = 1.87 ± 0.82) (p > 0.05). 
DISCUSSION
The major findings of the present study included a de-
crease in the incidence of coughing at the emergence from 
the general anesthesia, and of sore throat during the post-
operative period in smokers, when the ETT cuff was inflat-
ed with alkalinized 2% lidocaine. Furthermore, intracuff  
lidocaine prevented a significant rise in the ETT intra- 
cuff pressure.
This study was limited to smokers because this group 
has underlying airway irritability. Strategies to attenuate 
the emergence phenomenon include extubation in a deep-
er plane of anesthesia, use of narcotics16, and use of lido-
caine11,12,14. Although many studies have been performed, 
a reliable technique for improving ETT tolerance has not 
been established for smokers. A study using nebulized li-
docaine prior to the induction of anesthesia demonstrated 
a significant decrease in procedure-related complications 
in smoking patients17. Altintas et al. demonstrated lower 
incidence of bucking at the time of extubation with the use 
of intracuff lidocaine13.  When lidocaine is used to inflate 
the ETT cuff, a higher tolerance for both tracheal11-14 and 
tracheotomy tubing12 is well demonstrated. However, a 
recent study failed to demonstrate the effectiveness of in-
tracuff non-alkalinized 4% lidocaine in reducing coughing 
during emergence from general anesthesia in smokers14 
who underwent anesthesia lasting less than 90 minutes. 
The main reason for this lack of effect may be due to a low-
er drug diffusion rate through the cuff because of the low 
drug pH, since lidocaine was not alkalinized.
In this study, the incidence of coughing was demonstra-
bly lower in the L group when compared with the S group. 
Time points
(minutes after tracheal intubation)
Group
Saline Lidocaine
T 0 15.9 ± 1.3 17.8 ± 2.1#
T 30 16.8 ± 6.4 17.2 ± 7.0
T 60 17.1 ± 6.7 17.9 ± 6.5
T 90 18.2 ± 8.4 17.5 ± 7.2
T 120 19.1 ± 9.0 16.3 ± 6.8
Tend of anesthesia 20.4 ± 9.1* 16.3 ± 5.7
Data shown as mean ± standard deviation. #p = 0.04 for the difference between groups in the same time point; *p = 0.04 for the difference 
between time points in the same group.
Table 2 – Intracuff pressure (cm H2O) throughout the anesthesia procedure
Saline
Lidocaine
100%
75%
50%
25%
0%
Coughing Sore throat
PACU
n = 20
n = 7
n = 0 n = 0
n = 3
n = 5
*p = < 0.001; **p = 0.02 
*
**
n = 11
n = 10
n = 2 n = 2
Hoarseness
PACU
Hoarseness
24h
Sore throat
24h
Figure 1 – Incidence of emergence coughing and tracheal 
morbidity present in the post-anesthesia care unit (PACU) 
and 24 hours after extubation. There were 25 patients 
in both groups. Saline = control group (0.9% saline - S 
group); lidocaine = treated group (alkalinized 2% lidocaine 
- L group).
SORE THROAT AND HOARSENESS
The incidence of sore throat was significantly lower in the 
L group than in the S group at the time of release from the 
PACU (p = 0.02). The incidence of sore throat at 24 hours 
after extubation, however, was similar in both groups 
(p = 0.07). It is remarkable, and unexpected, that not a 
single patient in the L group had sore throat in the postop-
erative period (Figure 1). 
The incidence of hoarseness in the postoperative evalu-
ation revealed no statistically significant differences within 
the two groups in the PACU, as well as at 24 hours after 
extubation (p = 0.77 and p = 1.0, respectively) (Figure 1).
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In the proportions used in this study (19 mL of lidocaine: 
1 mL of bicarbonate), a solution pH modification from 
6.92 (lidocaine chlorohydrate) to 7.43 (alkalinized lido-
caine) was obtained.  This most likely provided for quicker 
diffusion of lidocaine through the cuff membrane, which 
allowed for the measurement of a similar significant lido-
caine concentration in the analysis of the patients’ blood 
samples just 10 minutes after inflation. The continuous me-
tabolism of lidocaine by the liver may explain the constant 
serum concentration of the drug found in this study. 
During general anesthesia, the use of intravenous li-
docaine has been employed with the intent of suppress-
ing cough reflex. To effectively suppress coughing, a high 
lidocaine serum concentration18, around 3 mg/mL1, is 
required. Such serum concentration may be achieved 
with an intravenous injection of 1-2 mg/kg1 of the drug19. 
Lidocaine administered intravenously, however, can pro-
duce sedation and prolong the process of awakening from 
anesthesia20. In this study, the patients did not experi-
ence any prolongation in the awakening from anesthesia 
time due to the use of intracuff lidocaine. In fact, the time 
elapsed since the discontinuation of the anesthetic drugs 
until the extubation was shorter in the L group. This may 
be due to a smoother emergence period experienced by 
the patients with intracuff lidocaine, while in the S group 
the high incidence of coughing during emergence delayed 
the extubation. 
The pressure in the ETT pilot balloon, an indirect 
measure of the pressure exerted by the cuff on the tra-
cheal mucosa, is not routinely determined by the anes-
thesiologist21,22. Several methods have been proposed to 
minimize the elevation of cuff pressure during N2O an-
esthesia. These include the use of an ETT with regulatory 
pressure valves23, the inflation of the cuff with a mixture of 
N2O/O2 in proportions identical to those used in the anes-
thesia24, the use of a tracheal tube with a cuff  impermeable 
to N2O25, and filling the cuff with 0.9% saline26. A reliable 
and alternative method of reducing high cuff pressure is 
filling the cuff with lidocaine. Others have used lidocaine 
in the form of chlorohydrate to fill the cuff in concentra-
tions of 2%, 4% and 10% (200-500 mg)8-10,13. Lidocaine 
alkalinization12 increases the rate of diffusion through the 
cuff wall, allowing a reduction of the lidocaine dose while 
achieving the same results. The ETT cuff served as a res-
ervoir to release local anesthetic to the subjacent tracheal 
tissues10,12. Our results demonstrate that intracuff lido-
caine prevents a significant rise in the cuff pressure during 
N2O anesthesia, secondary to continuous drug diffusion. 
On the other hand, there was a time-dependent increase 
in the cuff pressure in the S group. The reason for the rise 
in intracuff pressure is likely due to the increased gas by 
absorption of N2O27. Gas was also removed from the cuffs 
filled with lidocaine. The increased cuff gas in the L group 
at extubation was counter-balanced by a decrease in the 
liquid volume due to diffusion of alkalinized lidocaine 
through the cuff wall. This balance maintained adequate 
cuff pressure and protected the airway against air leak or 
aspiration of gastric content.
Cuff lubrication with lidocaine gel or spray has been 
associated with increased morbidity during emergence 
from anesthesia due to adherence of the ETT to the tra-
cheal mucosa28, and may promote cuff rupture29. Con-
trarily, cuff lubrication with a water soluble gel in asso-
ciation with alkalinized lidocaine increases tracheal tube 
tolerance and reduces the incidence of postoperative sore 
throat28. It has been suggested that sore throat is caused by 
the activation of tracheal pain receptors20. The proposal of 
a continuous application of local anesthetic to block these 
nociceptive receptors would therefore seem logical, in an 
attempt to reduce the incidence of sore throat. After tra-
cheal extubation, sore throat has been reported in 15% to 
80%13,30 of cases. In our study, the incidence of sore throat 
was 20% and 12% in the S group at the time of discharge 
from the PACU and at 24h after extubation, respectively. 
In the L group, no patient presented with sore throat. This 
highly positive result was unexpected and may be related 
with the combination of three different techniques recog-
nized as protective against sore throat: use of low ETT cuff 
pressure, use of intracuff alkalinized lidocaine, and use of 
water-soluble lubricant. However, despite all techniques 
applied for preventing tracheal morbidity, the incidence 
of hoarseness was similar in both groups, suggesting that 
this symptom is unlikely related to the cuff pressure or to 
the cuff inflation solution.
The toxicity of local anesthetic must be considered. 
The mean volume of lidocaine used in the study was 
6.9 ± 2.6 mL (138 ± 52 mg). This dose is lower than the 
toxic systemic level. If a cuff rupture occurs, a relatively 
high dose of lidocaine can be delivered into the trachea 
and bronchium leading to toxicity. However, lidocaine in-
duced cuff rupture has never been reported either in vivo 
or in vitro. In this study, all patients were extubated with-
out any complications, and no evidence of cuff damage 
was observed. Bicarbonate is another drug that can lead 
to tracheal wall damage if a cuff rupture occurs. The small 
dose used in the present study (1 mL of 8.4% bicarbon-
ate in 20 mL of solution) was enough to increase the pH 
of the lidocaine solution, and facilitate its diffusion, but 
is unlikely to produce damage on the trachea if any cuff 
damage occurs.
CONCLUSION
The present study demonstrated that the inflation of the 
ETT cuff with alkalinized 2% lidocaine was superior to 
saline in decreasing the incidence of emergence cough-
ing and preventing sore throat during the postoperative 
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period in smokers. The low cuff pressure and the lubrica-
tion of the ETT cuff may have helped to reduce cough-
ing and sore throat incidence, but these were used in both 
groups. We recommend considering the use of an ETT 
cuff filled with alkalinized lidocaine in smokers undergo-
ing general anesthesia.
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